title: Pharmacokinetics of CTLA4Ig (BMS-188667), a novel immunosuppressive agent, following intravenous and subcutaneous administration to mice.
authors: N R
authors: NR
authors: Srinivas
authors: W C
authors: WC
authors: Shyu
authors: R S
authors: RS
authors: Weiner
authors: L K
authors: LK
authors: Tay
authors: D S
authors: DS
authors: Greene
authors: R H
authors: RH
authors: Barbhaiya
mesh_terms: D000069594:Abatacept; D000818:Animals; D015703:Antigens, CD; D000943:Antigens, Differentiation / Q000008:administration & dosage*; D060908:CTLA-4 Antigen; D005260:Female; D006207:Half-Life; D018796:Immunoconjugates; D007166:Immunosuppressive Agents / Q000008:administration & dosage*; D007275:Injections, Intravenous; D007279:Injections, Subcutaneous; D051379:Mice
chemical_list: D015703:Antigens, CD; D000943:Antigens, Differentiation; D060908:CTLA-4 Antigen; C556707:Ctla4 protein, mouse; D018796:Immunoconjugates; D007166:Immunosuppressive Agents; D000069594:Abatacept